Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
World Vitiligo Map
Your guide to the vitiligo community worldwide. Use the selector to filter by patient support groups, specialists, research centers, clinical trial locations, or World Vitiligo Day events.
Directory Information & Disclaimer
This free public directory gathers information from public sources to help connect our global community. Medical professionals and organizations listed are independent and not affiliated with or endorsed by the Vitiligo Research Foundation (VRF), and no fees are accepted for listings.
Because clinics, support groups, and specialists move or update their services over time, some information may occasionally become outdated. As a result, VRF cannot guarantee the complete accuracy or usefulness of listed third-party resources.
Help Us Keep the Map Accurate
Do you need to add a listing, update outdated details, or request a removal? Please reach out to us using the feedback form on our Contact Us page.
Search Map
44 records found for “NCT07047612” · show all
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoHospital for Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, Jiangsu, 210042, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoShenyang Medical College Affiliated Central Hospital, Shenyang, Liaoning, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoSichuan Provincial People's Hospital, Chengdu, Sichuan, 610072, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoAffiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, China
021-52887775
FAQOther Questions
- Is it Bitiligo? Vitaligo? Veteligo?
There are so many different ways that people try and spell or even pronounce Vitiligo. Here are some common mis-spellings: bitiligo, vitigo, vitaligo, vitilago, vitiglio, vitag...
- Shall I take vitamin D for my vitiligo?
Vitamin D plays a central role in the prevention of different inflammatory and chronic diseases. Consuming 1,000–4,000 IU (25–100 mcg) of vitamin D3 daily should be ideal for mo...
- How long does it take to treat vitiligo?
Vitiligo, a condition characterized by the loss of skin pigment, can be unpredictable in both progression and treatment. The time it takes to treat vitiligo varies significantly...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.